Back to search

Article

Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers

2025-02-05

Abstract excerpt

<h4>ABSTRACT</h4> Genes involved in the regulation of chromatin structure are frequently disrupted in cancer, contributing to an aberrant transcriptome and phenotypic plasticity. Yet, therapeutics targeting mutant forms of chromatin-modifying enzymes have yielded only modest clinical utility, underscoring the difficulty of targeting the epigenomic underpinnings of aberrant gene regulatory networks. Here, we sough...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6c4217a-e7a9-5ad3-9281-80c93324aef4
DOI
10.1101/2025.01.31.635709
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancersDOI 10.1101/2025.01.31.635709
Select a neighboring publication to make it the new centre.